Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For people with brain cancer:
- Adults aged 18 or older
- Service members, Veterans, or civilians who have been diagnosed with brain cancer (not including glioblastoma)
- People diagnosed with a primary brain tumor — such as low-grade glioma, oligodendroglioma, IDH mutant astrocytoma, or meningioma — where doctors expect survival of 2 years or more, confirmed by brain scans and tissue testing (confirm with trial site)
- People who finished surgery and/or radiation treatment at least 3 months before joining the trial (those still receiving chemotherapy or other ongoing drug treatments may still be considered)
- People whose brain-related medications have remained unchanged for at least one month before joining
- People who have noticed problems with their own memory or thinking
- People who can read and write in English
- People with internet access for the first part of the program and phone access for later sessions
For caregivers of people with brain cancer:
- Adults aged 18 or older who care for someone diagnosed with a brain tumor
- Caregivers whose family member or patient has given permission for them to take part
- People who can read and write in English
- People with internet access for the early sessions and phone access for a later session
Who may not be able to join:
For people with brain cancer:
- People who have a neurodegenerative disease, such as Alzheimer's disease or Parkinson's disease
- People with an active serious psychiatric condition or substance abuse problem
- People diagnosed with glioblastoma (GBM)
For caregivers:
- People with significant vision impairment that prevents reading or writing
- People without reliable phone or internet access
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Elaine T Kiriakopoulos, MD, MPH, MSc, Dartmouth-Health/Dartmouth-Hitchcock, Dartmouth College
Phone: 603-650-4225
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in quality of life as measured by comparing Neuro-QOL scores at baseline and at 3 months post-intervention in CA Participants.; Change in quality of life as measured by comparing FACT-Br scores at baseline and at 3 months post-intervention in CA Participants.; Change in subjective cognitive function as measured by comparing scores on the Cognitive Function Sub-Scale (Item Bank 2.0) of the Neuro-QOL at baseline and at 3 months post-intervention in CA Participants.; Change in CA Participant Caregiver burden as measured by comparing Zarit Burden Interview scores at baseline and at 3 months...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.